Online Only Articles

Towards personalized therapy in pediatric acute lymphoblastic leukemia: RAS mutations and prednisolone resistance

Department of Pediatric Oncology/Hematology, Erasmus Medical Center-Sophia Children’s Hospital, Rotterdam
Department of Pediatric Oncology/Hematology, Erasmus Medical Center-Sophia Children’s Hospital, Rotterdam
Department of Medical Genetics, University Medical Center Utrecht;Center for Personalized Cancer Treatment
Department of Medical Genetics, University Medical Center Utrecht;Center for Personalized Cancer Treatment
Department of Medical Genetics, University Medical Center Utrecht;Center for Personalized Cancer Treatment
Department of Human Genetics, Academic Medical Centre, University of Amsterdam;Individualized Therapies for Children with Cancer Study Group
Department of Human Genetics, Academic Medical Centre, University of Amsterdam;Individualized Therapies for Children with Cancer Study Group
Department of Pediatric Oncology/Hematology, Erasmus Medical Center-Sophia Children’s Hospital, Rotterdam;Individualized Therapies for Children with Cancer Study Group;Dutch Childhood Oncology Group, The Hague, The Netherlands
Department of Pediatric Oncology/Hematology, Erasmus Medical Center-Sophia Children’s Hospital, Rotterdam;Individualized Therapies for Children with Cancer Study Group;Dutch Childhood Oncology Group, The Hague, The Netherlands
Vol. 100 No. 4 (2015): April, 2015 https://doi.org/10.3324/haematol.2014.112995